Beijing Kawin Technology Share-Holding Co., Ltd.

SHSE:688687 Stock Report

Market Cap: CN¥4.3b

Beijing Kawin Technology Share-Holding Past Earnings Performance

Past criteria checks 4/6

Beijing Kawin Technology Share-Holding has been growing earnings at an average annual rate of 13.3%, while the Biotechs industry saw earnings growing at 7.6% annually. Revenues have been growing at an average rate of 13% per year. Beijing Kawin Technology Share-Holding's return on equity is 8.6%, and it has net margins of 9.5%.

Key information

13.3%

Earnings growth rate

7.1%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate13.0%
Return on equity8.6%
Net Margin9.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)

Oct 28
Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)

Recent updates

Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)

Oct 28
Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)

Why Investors Shouldn't Be Surprised By Beijing Kawin Technology Share-Holding Co., Ltd.'s (SHSE:688687) 36% Share Price Surge

Oct 01
Why Investors Shouldn't Be Surprised By Beijing Kawin Technology Share-Holding Co., Ltd.'s (SHSE:688687) 36% Share Price Surge

We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

May 06
We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt

Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Mar 14
Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Revenue & Expenses Breakdown

How Beijing Kawin Technology Share-Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688687 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,420134828170
30 Jun 241,440121888152
31 Mar 241,518117969142
31 Dec 231,412117899134
30 Sep 231,326105890113
30 Jun 231,23685867106
31 Mar 231,18180855116
31 Dec 221,16083852114
30 Sep 221,2759895496
30 Jun 221,18410988990
31 Mar 221,14411184688
31 Dec 211,14410784977
30 Sep 211,0339874170
30 Jun 211,0028571667
31 Mar 219128063960
31 Dec 208627660356
30 Sep 208255560751
31 Dec 198255461835
31 Dec 187064550853
31 Dec 174912735443
31 Dec 15268241630
31 Dec 14225121310
31 Dec 13200171020

Quality Earnings: 688687 has a high level of non-cash earnings.

Growing Profit Margin: 688687's current net profit margins (9.5%) are higher than last year (7.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688687's earnings have grown by 13.3% per year over the past 5 years.

Accelerating Growth: 688687's earnings growth over the past year (27.6%) exceeds its 5-year average (13.3% per year).

Earnings vs Industry: 688687 earnings growth over the past year (27.6%) exceeded the Biotechs industry 1.3%.


Return on Equity

High ROE: 688687's Return on Equity (8.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies